Search

Now showing items 11-14 of 14

Prognostic factors for survival in children who relapsed after allogeneic hematopoietic stem cell transplantation for acute leukemia

Hazar, Volkan; Tezcan Karasu, Gulsun; Ozturk, Gulyuz; Kupesiz, Alphan; Aksoylar, Serap; Ozbek, Namık; Uygun, Vedat; Ileri, Talia; Okur, Fatma Visal; Kocak, Ulker; Caki Kilic, Suar; Akcay, Arzu; Guler, Elif; Kansoy, Savas; Karakukcu, Musa; Bayram, Ibrahim; Aksu , Tekin; Yesilipek, Akif; Karagun, Barbaros Sahin; Yilmaz, Sebnem; Ertem, Mehmet; Uckan, Duygu; Fisgin, Tunc; Gursel, Orhan; Yaman, Yöntem; Bozkurt, Ceyhun; Gokce, Muge (2020)

Background: Post-transplant relapse has a dismal prognosis in children with acute leukemia undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). Data on risk factors, treatment options, and outcomes ...

Comparison of hematopoietic stem cell transplantation results in patients with β-thalassemia major from three different graft types

Aydogdu, Selime; Toret, Ersin; Adakli Aksoy, Basak; Aydin, Muhammed Fatih; Erol Cipe, Funda; Bozkurt, Ceyhun; Fisgin, Tunc (Taylor & Francis Online, 2021)

Allogeneic hematopoietic stem cell transplantation (HSCT) is the curative therapy for β-thalassemias that induces severe life-threatening complications. The human leukocyte antigen (HLA) registries and umbilical cord blood ...

The use of allogeneic mesenchymal stem cells in childhood steroid-resistant acute graft-versus-host disease: a retrospective study of a single-center experience

Bozkurt, Ceyhun; Karaoz, Erdal; Adakli Aksoy, Basak; Aydogdu, Selime; Fisgin, Tunc (Galenos Yayincilik, 2019)

Objective: Steroid-resistant acute graft-versus-host disease (srAGVHD) is the most important cause of morbidity and mortality after allogeneic stem cell transplantation. There are several treatment methods available, ...

Could the COVID-19 infection have a better prognosis than expected in pediatric hematology oncology and bone marrow transplant patients?

Oner, Ozlem Basoglu; Aksoy, Basak Adakli; Yaman, Ayhan; Sutcu, Murat; Cipe, Funda; Atca, Ali Onder; Bozkurt, Ceyhun; Fisgin, Tunc (AVES, 2021)

Coronavirus disease 2019 (COVID-19) is a pandemic that spread rapidly worldwide (1). So far, very few reports concerning the impact of COVID-19 among patients with pediatric hematologic-oncologic diseases are available ...